Health
Novel formulation could provide a better treatment for patients with prostate cancer – News-Medical.Net
A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the …
Reviewed by Emily Henderson, B.Sc.Jun 20 2020
A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of life for p…
-
General13 hours agoBoy dies in foyer of Queensland police station after crash at Ormeau
-
Noosa News19 hours agoMS is not holding Lynda MacCallum back from staying in the saddle
-
Business18 hours agoUp 117% in six months! Pilbara Minerals shares lead the charge as ASX lithium stocks rally
-
Noosa News16 hours agoFamily rush to Beenleigh Police Station in Queensland with critically injured child following crash